These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 34587881)

  • 41. Electrospraying as a novel method of particle engineering for drug delivery vehicles.
    Tanhaei A; Mohammadi M; Hamishehkar H; Hamblin MR
    J Control Release; 2021 Feb; 330():851-865. PubMed ID: 33137365
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug Delivery Applications of Nanoparticles in the Spine.
    Venugopal I; Mehta AI; Linninger AA
    Methods Mol Biol; 2020; 2059():121-143. PubMed ID: 31435918
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Advances and challenges of nanotechnology-based drug delivery systems.
    Jiang W; Kim BY; Rutka JT; Chan WC
    Expert Opin Drug Deliv; 2007 Nov; 4(6):621-33. PubMed ID: 17970665
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recent advances in nanotechnology for the treatment of metabolic syndrome.
    Bahadori E; Farjami Z; Rezayi M; Lngari H; Darroudi M; Avan A; Ghayour-Mobarhan M
    Diabetes Metab Syndr; 2019; 13(2):1561-1568. PubMed ID: 31336522
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent update of toxicity aspects of nanoparticulate systems for drug delivery.
    Patnaik S; Gorain B; Padhi S; Choudhury H; Gabr GA; Md S; Kumar Mishra D; Kesharwani P
    Eur J Pharm Biopharm; 2021 Apr; 161():100-119. PubMed ID: 33639254
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems.
    Sharma A; Madhunapantula SV; Robertson GP
    Expert Opin Drug Metab Toxicol; 2012 Jan; 8(1):47-69. PubMed ID: 22097965
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Understanding the mechanisms of silica nanoparticles for nanomedicine.
    Li Z; Mu Y; Peng C; Lavin MF; Shao H; Du Z
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1658. PubMed ID: 32602269
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patents on nanoparticulate drug delivery systems--a review.
    Bhavna ; Ali M; Baboota S; Ali J
    Recent Pat Drug Deliv Formul; 2008; 2(1):83-9. PubMed ID: 19075900
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detecting and destroying cancer cells in more than one way with noble metals and different confinement properties on the nanoscale.
    Dreaden EC; El-Sayed MA
    Acc Chem Res; 2012 Nov; 45(11):1854-65. PubMed ID: 22546051
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Update on Nanotechnology-based Drug Delivery Systems in Cancer Treatment.
    Ho BN; Pfeffer CM; Singh ATK
    Anticancer Res; 2017 Nov; 37(11):5975-5981. PubMed ID: 29061776
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Advances in Biomimetic Nanoparticles for Targeted Cancer Therapy and Diagnosis.
    Beh CY; Prajnamitra RP; Chen LL; Hsieh PC
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443638
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Production methods for nanodrug particles using the bottom-up approach.
    Chan HK; Kwok PC
    Adv Drug Deliv Rev; 2011 May; 63(6):406-16. PubMed ID: 21457742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Process⁻Property⁻Performance Relationship of Medicated Nanoparticles Prepared by Modified Coaxial Electrospraying.
    Huang W; Hou Y; Lu X; Gong Z; Yang Y; Lu XJ; Liu XL; Yu DG
    Pharmaceutics; 2019 May; 11(5):. PubMed ID: 31083358
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Applications of electrospinning/electrospraying in drug delivery.
    Jahangiri A; Adibkia K
    Bioimpacts; 2016; 6(1):1-2. PubMed ID: 27340617
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The importance of microfluidics for the preparation of nanoparticles as advanced drug delivery systems.
    Martins JP; Torrieri G; Santos HA
    Expert Opin Drug Deliv; 2018 May; 15(5):469-479. PubMed ID: 29508630
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Engineered magnetic nanoparticles for biomedical applications.
    Canfarotta F; Piletsky SA
    Adv Healthc Mater; 2014 Feb; 3(2):160-75. PubMed ID: 24497448
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
    Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mesoporous silica nanoparticles in drug delivery and biomedical applications.
    Wang Y; Zhao Q; Han N; Bai L; Li J; Liu J; Che E; Hu L; Zhang Q; Jiang T; Wang S
    Nanomedicine; 2015 Feb; 11(2):313-27. PubMed ID: 25461284
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nanotechnology: a focus on nanoparticles as a drug delivery system.
    Kingsley JD; Dou H; Morehead J; Rabinow B; Gendelman HE; Destache CJ
    J Neuroimmune Pharmacol; 2006 Sep; 1(3):340-50. PubMed ID: 18040810
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmaceutical and Biomedical Applications of Green Synthesized Metal and Metal Oxide Nanoparticles.
    Zafar N; Madni A; Khalid A; Khan T; Kousar R; Naz SS; Wahid F
    Curr Pharm Des; 2020; 26(45):5844-5865. PubMed ID: 33243108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.